未登录

刘

刘晓辉 (Xiaohui Liu)

ocean university of china

H指数:32

被引数:3,292

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Extracellular vesicles in the plastisphere emerge as hotspots to spread antibiotic resistance and virulence genes

plastisphere中的细胞外囊泡成为传播抗生素耐药性和毒力基因的热点

IF15.3

2026-04-280

PRE

Development and Application of a Rapid Field Detection Technology for DENV-2 Based on the HUDSON Nucleic Acid Extraction-Free/RT-RAA/CRISPR-Cas12a System

基于HUDSON核酸提取-free/RT-RAA/CRISPR-Cas12a系统的DENV-2快速现场检测技术的开发与应用

Viruses 2025, Vol. 17, Page 1579

IF3.5

2025-12-020

OAAI

Visualization of Met dimerization and cell migration interference by aptamer terminated tripodal DNA coacervates

适配体终止的三足DNA共聚物对Met二聚化和细胞迁移干扰的可视化

Journal of Colloid and Interface Science

IF9.7

2025-08-150

PRE

Construction of Somatostatin-Based Multiphase Core-Shell Coacervates as Photodynamic Biomimetic Organelles

ADVANCED HEALTHCARE MATERIALS

IF9.6

2024-11-050

PRE

Advances of engineered microfluidic biosensors via CRISPR/Cas in bacteria and virus monitoring

CHEMICAL ENGINEERING JOURNAL

IF13.2

2024-07-013

PRE

Znf687 recruits Brd4-Smrt complex to regulate gfi1aa during neutrophil development

IF13.4

2024-02-070

PRE

Decreasing the intrinsically disordered protein α-synuclein levels by targeting its structured mRNA with a ribonuclease- targeting chimera

通过靶向核糖核酸酶的嵌合体靶向其结构化mRNA来降低内在无序的蛋白质 α-突触核蛋白水平

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2024-01-058

OAAI

An mRNA vaccine against rabies provides strong and durable protection in mice

抗狂犬病的mRNA疫苗在小鼠中提供了强大而持久的保护

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-10-2614

OAAI

LAIR1 drives glioma progression by nuclear focal adhesion kinase dependent expressions of cyclin D1 and immunosuppressive chemokines/cytokines

CELL DEATH & DISEASE

IF9.6

2023-10-165

OAAI

Endogenous miRNA and K+ Co-Activated Dynamic Assembly of DNA Coacervates for Intracellular miRNA Imaging and Mitochondrial Intervention

ANALYTICAL CHEMISTRY

IF6.7

2023-09-064

PRE

Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-27221

OAAI

STAGA recruits mediator to the MYC oncoprotein to stimulate transcription and cell proliferation

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2788

OAAI

Target-initiated DNA release-directed catalytic hairpin assembly-based ultrasensitive cyclic amplification sensor detection of serum miRNA

基于靶向启动DNA释放定向催化发夹组装的超灵敏循环扩增传感器检测血清miRNA

ANALYTICA CHIMICA ACTA

IF6

2022-11-014

PRE

CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation

CELL AND BIOSCIENCE

IF6.2

2022-10-0911

OAAI

Ultraprecise Real-Time Monitoring of Single Cells in Tumors in Response to Metal Ion-Mediated RNA Delivery

响应于金属离子介导的RNA递送的肿瘤中单细胞的超精密实时监测

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2022-08-1611

PRE

Aptamer-armed nanostructures improve the chemotherapy outcome of triple-negative breast cancer

MOLECULAR THERAPY

IF12

2022-06-0112

OA

Aptamer-Gemcitabine Conjugates with Enzymatically Cleavable Linker for Targeted Delivery and Intracellular Drug Release in Cancer Cells

PHARMACEUTICALS

IF4.8

2022-04-3010

OAAI

Association of Corticosteroid Treatment With Outcomes in Pediatric Patients With Bacterial Meningitis: A Systematic Review and Meta-analysis of Randomized Controlled Trials

CLINICAL THERAPEUTICS

IF3.6

2022-04-014

PRE

Advances in COVID-19 mRNA vaccine development

新型冠状病毒肺炎mRNA疫苗的研究进展

Signal Transduction and Targeted Therapy

IF52.7

2022-03-230

OAAI

Anti-inflammatory activity of total flavonoids from seeds of Camellia oleifera Abel

ACTA BIOCHIMICA ET BIOPHYSICA SINICA

IF3.4

2022-03-0345

PREAI

研究方向

纳米医学生物传感器与生物电子学靶向纳米机器人基于体内生物合成纳米团簇的多模式自生物成像与肿瘤阿尔茨海默病治疗纳米级分子探针细菌识别与区分癌细胞和耐药细胞用于纳米医学的多功能智能生物相容性纳米结构的设计无创分子治疗新策略超分子生物识别和生物纳米技术生物分子/细胞/体内生物成像活体肿瘤病变部位荧光和磁性纳米团簇的原位生物合成新型体内成像策略肿瘤和其他相关疾病的精确靶向生物标记快速实时和跨尺度生物成像/治疗

H 指数:61论文数:735被引数:1.5万

H 指数:75论文数:921被引数:1.9万

H 指数:48论文数:341被引数:9,805

H 指数:38论文数:140被引数:5,292

H 指数:59论文数:505被引数:1.4万

H 指数:99论文数:1,161被引数:3.8万

Yan‐Shang Kang

H 指数:27论文数:65被引数:2,729

H 指数:22论文数:47被引数:1,480

H 指数:59论文数:700被引数:1.5万

H 指数:34论文数:127被引数:4,972